FDA approves new hepatitis B treatment bepirovirsen (Hibsago) by GSK for adults with chronic HBV infection.
Healthcare leaders say shifting from a perfection mindset to a learning culture reduces fear of errors and promotes…
The American Society of Nephrology Kidney Week 2026 convened in Denver from Oct. 21-25, drawing clinicians and researchers…
The U.S. Food and Drug Administration is expected to issue its decision before the close of 2026 on…
AI raises concerns in healthcare systems, potentially worsening disparities if biases go unchecked, about ai healthcare.
FDA approves new hepatitis B treatment bepirovirsen (Hibsago) by GSK for adults with chronic HBV infection.
The FDA has expanded the approval of tildrakizumab for adults with active psoriatic arthritis, adding to its use…
Tenet Healthcare raises 2026 earnings guidance by focusing on high-value surgeries, stabilizing finances amid weak surgical market and…
AI models give wrong medication doses in about 2% of cases, Doximity research finds, raising concerns about AI…
Massachusetts judge blocks CMS medical frailty definition exempting Medicaid enrollees from work requirements, a decision reshaping eligibility rules.
UHS cuts 2026 earnings forecast amid surgery decline, outpatient shift.
